Teva Pharmaceuticals
FDA previously categorized more than a dozen peptides as category 2 substances and deemed them unsafe for bulk compounding in 2023
World Anti-Doping Agency (WADA): Prohibited List (includes BPC-157 as an example under S0 in current lists)
5-Amino-1MQ may inhibit NNMT activity with possible effects on NAD+ and S-adenosylmethionine (SAM) dynamics in experimental models

INGREDIENTS Water/Aqua, Glycerin,Butylene Glycol Dicaprylate/Dicaprate, Dipropylene Glycol, Pentaerythrityl Tetraethylhexanoate, Niacinamide, Squalane, C9-12 Alkane, Panthenol, Hydrolyzed Hyaluronic Acid, Hyaluronic Acid, Hydroxypropyltrimonium Hyaluronate, Sodium Hyaluronate, Sodium Acetylated Hyaluronate, Sodium Hyaluronate Crosspolymer, Hydrolyzed Sodium Hyaluronate, Potassium Hyaluronate, Bisabolol, Ferulic Acid, Potassium Cetyl Phosphate,1,2 Hexanediol, Hydroxyacetophenone, Glutathione, Tocopherol, Vaccinium Macrocarpon (Cranberry) Fruit Extract, Allantoin, Chamomilla Recutita (Matricaria) Flower Extract, Malt Extract, Ubiquinone, Oryza Sativa (Rice) Bran Extract, Tromethamine, Isohexadecane, Butylene Glycol, Xanthan Gum,3-O-Ethyl Ascorbic Acid, Tocopheryl Acetate, Sorbitan Oleate, Adenosine, t-Butyl Alcohol, Glucose, Ascorbic Acid, C14-22 Alcohols, Glyceryl Acrylate/Acrylic Acid Copolymer, Polysorbate 80,C12-20 Alkyl Glucoside, Polyacrylate Crosspolymer-6,Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Disodium EDTA
